Table of Content

1 Study Coverage
1.1 Biological Vaccines Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Biological Vaccines Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biological Vaccines Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biological Vaccines Adjuvants Sales Estimates and Forecasts 2018-2029
2.2 Global Biological Vaccines Adjuvants Revenue by Region
2.2.1 Global Biological Vaccines Adjuvants Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biological Vaccines Adjuvants Revenue by Region (2018-2024)
2.2.3 Global Biological Vaccines Adjuvants Revenue by Region (2024-2029)
2.2.4 Global Biological Vaccines Adjuvants Revenue Market Share by Region (2018-2029)
2.3 Global Biological Vaccines Adjuvants Sales Estimates and Forecasts 2018-2029
2.4 Global Biological Vaccines Adjuvants Sales by Region
2.4.1 Global Biological Vaccines Adjuvants Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biological Vaccines Adjuvants Sales by Region (2018-2024)
2.4.3 Global Biological Vaccines Adjuvants Sales by Region (2024-2029)
2.4.4 Global Biological Vaccines Adjuvants Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biological Vaccines Adjuvants Sales by Manufacturers
3.1.1 Global Biological Vaccines Adjuvants Sales by Manufacturers (2018-2024)
3.1.2 Global Biological Vaccines Adjuvants Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological Vaccines Adjuvants in 2022
3.2 Global Biological Vaccines Adjuvants Revenue by Manufacturers
3.2.1 Global Biological Vaccines Adjuvants Revenue by Manufacturers (2018-2024)
3.2.2 Global Biological Vaccines Adjuvants Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biological Vaccines Adjuvants Revenue in 2022
3.3 Global Key Players of Biological Vaccines Adjuvants, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biological Vaccines Adjuvants Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biological Vaccines Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biological Vaccines Adjuvants, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biological Vaccines Adjuvants, Product Offered and Application
3.8 Global Key Manufacturers of Biological Vaccines Adjuvants, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biological Vaccines Adjuvants Sales by Type
4.1.1 Global Biological Vaccines Adjuvants Historical Sales by Type (2018-2024)
4.1.2 Global Biological Vaccines Adjuvants Forecasted Sales by Type (2024-2029)
4.1.3 Global Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
4.2 Global Biological Vaccines Adjuvants Revenue by Type
4.2.1 Global Biological Vaccines Adjuvants Historical Revenue by Type (2018-2024)
4.2.2 Global Biological Vaccines Adjuvants Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
4.3 Global Biological Vaccines Adjuvants Price by Type
4.3.1 Global Biological Vaccines Adjuvants Price by Type (2018-2024)
4.3.2 Global Biological Vaccines Adjuvants Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biological Vaccines Adjuvants Sales by Application
5.1.1 Global Biological Vaccines Adjuvants Historical Sales by Application (2018-2024)
5.1.2 Global Biological Vaccines Adjuvants Forecasted Sales by Application (2024-2029)
5.1.3 Global Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
5.2 Global Biological Vaccines Adjuvants Revenue by Application
5.2.1 Global Biological Vaccines Adjuvants Historical Revenue by Application (2018-2024)
5.2.2 Global Biological Vaccines Adjuvants Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
5.3 Global Biological Vaccines Adjuvants Price by Application
5.3.1 Global Biological Vaccines Adjuvants Price by Application (2018-2024)
5.3.2 Global Biological Vaccines Adjuvants Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biological Vaccines Adjuvants Market Size by Type
6.1.1 US & Canada Biological Vaccines Adjuvants Sales by Type (2018-2029)
6.1.2 US & Canada Biological Vaccines Adjuvants Revenue by Type (2018-2029)
6.2 US & Canada Biological Vaccines Adjuvants Market Size by Application
6.2.1 US & Canada Biological Vaccines Adjuvants Sales by Application (2018-2029)
6.2.2 US & Canada Biological Vaccines Adjuvants Revenue by Application (2018-2029)
6.3 US & Canada Biological Vaccines Adjuvants Market Size by Country
6.3.1 US & Canada Biological Vaccines Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biological Vaccines Adjuvants Sales by Country (2018-2029)
6.3.3 US & Canada Biological Vaccines Adjuvants Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biological Vaccines Adjuvants Market Size by Type
7.1.1 Europe Biological Vaccines Adjuvants Sales by Type (2018-2029)
7.1.2 Europe Biological Vaccines Adjuvants Revenue by Type (2018-2029)
7.2 Europe Biological Vaccines Adjuvants Market Size by Application
7.2.1 Europe Biological Vaccines Adjuvants Sales by Application (2018-2029)
7.2.2 Europe Biological Vaccines Adjuvants Revenue by Application (2018-2029)
7.3 Europe Biological Vaccines Adjuvants Market Size by Country
7.3.1 Europe Biological Vaccines Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biological Vaccines Adjuvants Sales by Country (2018-2029)
7.3.3 Europe Biological Vaccines Adjuvants Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biological Vaccines Adjuvants Market Size
8.1.1 China Biological Vaccines Adjuvants Sales (2018-2029)
8.1.2 China Biological Vaccines Adjuvants Revenue (2018-2029)
8.2 China Biological Vaccines Adjuvants Market Size by Application
8.2.1 China Biological Vaccines Adjuvants Sales by Application (2018-2029)
8.2.2 China Biological Vaccines Adjuvants Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biological Vaccines Adjuvants Market Size by Type
9.1.1 Asia Biological Vaccines Adjuvants Sales by Type (2018-2029)
9.1.2 Asia Biological Vaccines Adjuvants Revenue by Type (2018-2029)
9.2 Asia Biological Vaccines Adjuvants Market Size by Application
9.2.1 Asia Biological Vaccines Adjuvants Sales by Application (2018-2029)
9.2.2 Asia Biological Vaccines Adjuvants Revenue by Application (2018-2029)
9.3 Asia Biological Vaccines Adjuvants Sales by Region
9.3.1 Asia Biological Vaccines Adjuvants Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biological Vaccines Adjuvants Revenue by Region (2018-2029)
9.3.3 Asia Biological Vaccines Adjuvants Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biological Vaccines Adjuvants Market Size by Type
10.1.1 Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biological Vaccines Adjuvants Market Size by Application
10.2.1 Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Country
10.3.1 Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Dynavax Technologies
11.2.1 Dynavax Technologies Company Information
11.2.2 Dynavax Technologies Overview
11.2.3 Dynavax Technologies Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Dynavax Technologies Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dynavax Technologies Recent Developments
11.3 Novavax
11.3.1 Novavax Company Information
11.3.2 Novavax Overview
11.3.3 Novavax Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novavax Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novavax Recent Developments
11.4 Agenus
11.4.1 Agenus Company Information
11.4.2 Agenus Overview
11.4.3 Agenus Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Agenus Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Agenus Recent Developments
11.5 Croda International
11.5.1 Croda International Company Information
11.5.2 Croda International Overview
11.5.3 Croda International Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Croda International Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Croda International Recent Developments
11.6 Seppic
11.6.1 Seppic Company Information
11.6.2 Seppic Overview
11.6.3 Seppic Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Seppic Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Seppic Recent Developments
11.7 OZ Biosciences
11.7.1 OZ Biosciences Company Information
11.7.2 OZ Biosciences Overview
11.7.3 OZ Biosciences Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 OZ Biosciences Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 OZ Biosciences Recent Developments
11.8 Phibro Animal Health Corporation
11.8.1 Phibro Animal Health Corporation Company Information
11.8.2 Phibro Animal Health Corporation Overview
11.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Phibro Animal Health Corporation Recent Developments
11.9 Associated British Foods
11.9.1 Associated British Foods Company Information
11.9.2 Associated British Foods Overview
11.9.3 Associated British Foods Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Associated British Foods Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Associated British Foods Recent Developments
11.10 InvivoGen
11.10.1 InvivoGen Company Information
11.10.2 InvivoGen Overview
11.10.3 InvivoGen Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 InvivoGen Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 InvivoGen Recent Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Overview
11.11.3 Merck KGaA Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Merck KGaA Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Merck KGaA Recent Developments
11.12 CSL Limited
11.12.1 CSL Limited Company Information
11.12.2 CSL Limited Overview
11.12.3 CSL Limited Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 CSL Limited Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CSL Limited Recent Developments
11.13 Vertellus
11.13.1 Vertellus Company Information
11.13.2 Vertellus Overview
11.13.3 Vertellus Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Vertellus Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vertellus Recent Developments
11.14 Allergy Therapeutics
11.14.1 Allergy Therapeutics Company Information
11.14.2 Allergy Therapeutics Overview
11.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Allergy Therapeutics Recent Developments
11.15 Riboxx GmbH
11.15.1 Riboxx GmbH Company Information
11.15.2 Riboxx GmbH Overview
11.15.3 Riboxx GmbH Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Riboxx GmbH Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Riboxx GmbH Recent Developments
11.16 CaPtivatϵ Pharmaceuticals
11.16.1 CaPtivatϵ Pharmaceuticals Company Information
11.16.2 CaPtivatϵ Pharmaceuticals Overview
11.16.3 CaPtivatϵ Pharmaceuticals Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 CaPtivatϵ Pharmaceuticals Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CaPtivatϵ Pharmaceuticals Recent Developments
11.17 EuBiologics
11.17.1 EuBiologics Company Information
11.17.2 EuBiologics Overview
11.17.3 EuBiologics Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 EuBiologics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 EuBiologics Recent Developments
11.18 Pacific GeneTech
11.18.1 Pacific GeneTech Company Information
11.18.2 Pacific GeneTech Overview
11.18.3 Pacific GeneTech Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Pacific GeneTech Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Pacific GeneTech Recent Developments
11.19 Hawaii Biotech
11.19.1 Hawaii Biotech Company Information
11.19.2 Hawaii Biotech Overview
11.19.3 Hawaii Biotech Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Hawaii Biotech Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Hawaii Biotech Recent Developments
11.20 Vaxine Pty Ltd.
11.20.1 Vaxine Pty Ltd. Company Information
11.20.2 Vaxine Pty Ltd. Overview
11.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Vaxine Pty Ltd. Recent Developments
11.21 Creative Diagnostics
11.21.1 Creative Diagnostics Company Information
11.21.2 Creative Diagnostics Overview
11.21.3 Creative Diagnostics Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Creative Diagnostics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Creative Diagnostics Recent Developments
11.22 LiteVax BV
11.22.1 LiteVax BV Company Information
11.22.2 LiteVax BV Overview
11.22.3 LiteVax BV Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 LiteVax BV Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 LiteVax BV Recent Developments
11.23 Mukta Industries
11.23.1 Mukta Industries Company Information
11.23.2 Mukta Industries Overview
11.23.3 Mukta Industries Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Mukta Industries Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Mukta Industries Recent Developments
11.24 Oncovir
11.24.1 Oncovir Company Information
11.24.2 Oncovir Overview
11.24.3 Oncovir Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.24.4 Oncovir Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Oncovir Recent Developments
11.25 TiterMax USA
11.25.1 TiterMax USA Company Information
11.25.2 TiterMax USA Overview
11.25.3 TiterMax USA Biological Vaccines Adjuvants Sales, Price, Revenue and Gross Margin (2018-2024)
11.25.4 TiterMax USA Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 TiterMax USA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biological Vaccines Adjuvants Industry Chain Analysis
12.2 Biological Vaccines Adjuvants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biological Vaccines Adjuvants Production Mode & Process
12.4 Biological Vaccines Adjuvants Sales and Marketing
12.4.1 Biological Vaccines Adjuvants Sales Channels
12.4.2 Biological Vaccines Adjuvants Distributors
12.5 Biological Vaccines Adjuvants Customers
13 Market Dynamics
13.1 Biological Vaccines Adjuvants Industry Trends
13.2 Biological Vaccines Adjuvants Market Drivers
13.3 Biological Vaccines Adjuvants Market Challenges
13.4 Biological Vaccines Adjuvants Market Restraints
14 Key Findings in The Global Biological Vaccines Adjuvants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biological Vaccines Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Aluminum Adjuvant
Table 3. Major Manufacturers of Emulsions Adjuvant
Table 4. Major Manufacturers of Others
Table 5. Global Biological Vaccines Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Biological Vaccines Adjuvants Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Biological Vaccines Adjuvants Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Biological Vaccines Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Biological Vaccines Adjuvants Revenue Market Share by Region (2018-2024)
Table 10. Global Biological Vaccines Adjuvants Revenue Market Share by Region (2024-2029)
Table 11. Global Biological Vaccines Adjuvants Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Biological Vaccines Adjuvants Sales by Region (2018-2024) & (K Units)
Table 13. Global Biological Vaccines Adjuvants Sales by Region (2024-2029) & (K Units)
Table 14. Global Biological Vaccines Adjuvants Sales Market Share by Region (2018-2024)
Table 15. Global Biological Vaccines Adjuvants Sales Market Share by Region (2024-2029)
Table 16. Global Biological Vaccines Adjuvants Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Biological Vaccines Adjuvants Sales Share by Manufacturers (2018-2024)
Table 18. Global Biological Vaccines Adjuvants Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Biological Vaccines Adjuvants Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Biological Vaccines Adjuvants, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Biological Vaccines Adjuvants Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Biological Vaccines Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Biological Vaccines Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Vaccines Adjuvants as of 2022)
Table 24. Global Key Manufacturers of Biological Vaccines Adjuvants, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Biological Vaccines Adjuvants, Product Offered and Application
Table 26. Global Key Manufacturers of Biological Vaccines Adjuvants, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 29. Global Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 30. Global Biological Vaccines Adjuvants Sales Share by Type (2018-2024)
Table 31. Global Biological Vaccines Adjuvants Sales Share by Type (2024-2029)
Table 32. Global Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Biological Vaccines Adjuvants Revenue Share by Type (2018-2024)
Table 35. Global Biological Vaccines Adjuvants Revenue Share by Type (2024-2029)
Table 36. Biological Vaccines Adjuvants Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Biological Vaccines Adjuvants Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 39. Global Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 40. Global Biological Vaccines Adjuvants Sales Share by Application (2018-2024)
Table 41. Global Biological Vaccines Adjuvants Sales Share by Application (2024-2029)
Table 42. Global Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Biological Vaccines Adjuvants Revenue Share by Application (2018-2024)
Table 45. Global Biological Vaccines Adjuvants Revenue Share by Application (2024-2029)
Table 46. Biological Vaccines Adjuvants Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Biological Vaccines Adjuvants Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Biological Vaccines Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Biological Vaccines Adjuvants Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Biological Vaccines Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Biological Vaccines Adjuvants Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Biological Vaccines Adjuvants Sales by Country (2024-2029) & (K Units)
Table 61. Europe Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 62. Europe Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 63. Europe Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 66. Europe Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 67. Europe Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Biological Vaccines Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Biological Vaccines Adjuvants Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Biological Vaccines Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Biological Vaccines Adjuvants Sales by Country (2018-2024) & (K Units)
Table 73. Europe Biological Vaccines Adjuvants Sales by Country (2024-2029) & (K Units)
Table 74. China Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 75. China Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 76. China Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 79. China Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 80. China Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 83. Asia Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 84. Asia Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 87. Asia Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 88. Asia Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Biological Vaccines Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Biological Vaccines Adjuvants Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Biological Vaccines Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Biological Vaccines Adjuvants Sales by Region (2018-2024) & (K Units)
Table 94. Asia Biological Vaccines Adjuvants Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales by Country (2024-2029) & (K Units)
Table 108. GSK Company Information
Table 109. GSK Description and Major Businesses
Table 110. GSK Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. GSK Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GSK Recent Developments
Table 113. Dynavax Technologies Company Information
Table 114. Dynavax Technologies Description and Major Businesses
Table 115. Dynavax Technologies Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Dynavax Technologies Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Dynavax Technologies Recent Developments
Table 118. Novavax Company Information
Table 119. Novavax Description and Major Businesses
Table 120. Novavax Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Novavax Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novavax Recent Developments
Table 123. Agenus Company Information
Table 124. Agenus Description and Major Businesses
Table 125. Agenus Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Agenus Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Agenus Recent Developments
Table 128. Croda International Company Information
Table 129. Croda International Description and Major Businesses
Table 130. Croda International Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Croda International Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Croda International Recent Developments
Table 133. Seppic Company Information
Table 134. Seppic Description and Major Businesses
Table 135. Seppic Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Seppic Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Seppic Recent Developments
Table 138. OZ Biosciences Company Information
Table 139. OZ Biosciences Description and Major Businesses
Table 140. OZ Biosciences Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. OZ Biosciences Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. OZ Biosciences Recent Developments
Table 143. Phibro Animal Health Corporation Company Information
Table 144. Phibro Animal Health Corporation Description and Major Businesses
Table 145. Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Phibro Animal Health Corporation Recent Developments
Table 148. Associated British Foods Company Information
Table 149. Associated British Foods Description and Major Businesses
Table 150. Associated British Foods Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Associated British Foods Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Associated British Foods Recent Developments
Table 153. InvivoGen Company Information
Table 154. InvivoGen Description and Major Businesses
Table 155. InvivoGen Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. InvivoGen Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. InvivoGen Recent Developments
Table 158. Merck KGaA Company Information
Table 159. Merck KGaA Description and Major Businesses
Table 160. Merck KGaA Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Merck KGaA Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Merck KGaA Recent Developments
Table 163. CSL Limited Company Information
Table 164. CSL Limited Description and Major Businesses
Table 165. CSL Limited Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. CSL Limited Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. CSL Limited Recent Developments
Table 168. Vertellus Company Information
Table 169. Vertellus Description and Major Businesses
Table 170. Vertellus Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Vertellus Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Vertellus Recent Developments
Table 173. Allergy Therapeutics Company Information
Table 174. Allergy Therapeutics Description and Major Businesses
Table 175. Allergy Therapeutics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Allergy Therapeutics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Allergy Therapeutics Recent Developments
Table 178. Riboxx GmbH Company Information
Table 179. Riboxx GmbH Description and Major Businesses
Table 180. Riboxx GmbH Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Riboxx GmbH Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Riboxx GmbH Recent Developments
Table 183. CaPtivatϵ Pharmaceuticals Company Information
Table 184. CaPtivatϵ Pharmaceuticals Description and Major Businesses
Table 185. CaPtivatϵ Pharmaceuticals Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. CaPtivatϵ Pharmaceuticals Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. CaPtivatϵ Pharmaceuticals Recent Developments
Table 188. EuBiologics Company Information
Table 189. EuBiologics Description and Major Businesses
Table 190. EuBiologics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. EuBiologics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. EuBiologics Recent Developments
Table 193. Pacific GeneTech Company Information
Table 194. Pacific GeneTech Description and Major Businesses
Table 195. Pacific GeneTech Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. Pacific GeneTech Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Pacific GeneTech Recent Developments
Table 198. Hawaii Biotech Company Information
Table 199. Hawaii Biotech Description and Major Businesses
Table 200. Hawaii Biotech Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Hawaii Biotech Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Hawaii Biotech Recent Developments
Table 203. Vaxine Pty Ltd. Company Information
Table 204. Vaxine Pty Ltd. Description and Major Businesses
Table 205. Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 206. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Vaxine Pty Ltd. Recent Developments
Table 208. Creative Diagnostics Company Information
Table 209. Creative Diagnostics Description and Major Businesses
Table 210. Creative Diagnostics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 211. Creative Diagnostics Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 212. Creative Diagnostics Recent Developments
Table 213. LiteVax BV Company Information
Table 214. LiteVax BV Description and Major Businesses
Table 215. LiteVax BV Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 216. LiteVax BV Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 217. LiteVax BV Recent Developments
Table 218. Mukta Industries Company Information
Table 219. Mukta Industries Description and Major Businesses
Table 220. Mukta Industries Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 221. Mukta Industries Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 222. Mukta Industries Recent Developments
Table 223. Oncovir Company Information
Table 224. Oncovir Description and Major Businesses
Table 225. Oncovir Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 226. Oncovir Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 227. Oncovir Recent Developments
Table 228. TiterMax USA Company Information
Table 229. TiterMax USA Description and Major Businesses
Table 230. TiterMax USA Biological Vaccines Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 231. TiterMax USA Biological Vaccines Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 232. TiterMax USA Recent Developments
Table 233. Key Raw Materials Lists
Table 234. Raw Materials Key Suppliers Lists
Table 235. Biological Vaccines Adjuvants Distributors List
Table 236. Biological Vaccines Adjuvants Customers List
Table 237. Biological Vaccines Adjuvants Market Trends
Table 238. Biological Vaccines Adjuvants Market Drivers
Table 239. Biological Vaccines Adjuvants Market Challenges
Table 240. Biological Vaccines Adjuvants Market Restraints
Table 241. Research Programs/Design for This Report
Table 242. Key Data Information from Secondary Sources
Table 243. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Vaccines Adjuvants Product Picture
Figure 2. Global Biological Vaccines Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biological Vaccines Adjuvants Market Share by Type in 2022 & 2029
Figure 4. Aluminum Adjuvant Product Picture
Figure 5. Emulsions Adjuvant Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biological Vaccines Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Biological Vaccines Adjuvants Market Share by Application in 2022 & 2029
Figure 9. Human Vaccine
Figure 10. Veterinary Vaccine
Figure 11. Biological Vaccines Adjuvants Report Years Considered
Figure 12. Global Biological Vaccines Adjuvants Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Biological Vaccines Adjuvants Revenue 2018-2029 (US$ Million)
Figure 14. Global Biological Vaccines Adjuvants Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Biological Vaccines Adjuvants Revenue Market Share by Region (2018-2029)
Figure 16. Global Biological Vaccines Adjuvants Sales 2018-2029 ((K Units)
Figure 17. Global Biological Vaccines Adjuvants Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Biological Vaccines Adjuvants Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Biological Vaccines Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Biological Vaccines Adjuvants Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Biological Vaccines Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Biological Vaccines Adjuvants Sales YoY (2018-2029) & (K Units)
Figure 23. China Biological Vaccines Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Biological Vaccines Adjuvants Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Biological Vaccines Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Biological Vaccines Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Biological Vaccines Adjuvants in the World: Market Share by Biological Vaccines Adjuvants Revenue in 2022
Figure 30. Global Biological Vaccines Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 32. Global Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 33. Global Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 34. Global Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Biological Vaccines Adjuvants Revenue Share by Country (2018-2029)
Figure 40. US & Canada Biological Vaccines Adjuvants Sales Share by Country (2018-2029)
Figure 41. U.S. Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 44. Europe Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 45. Europe Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 46. Europe Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 47. Europe Biological Vaccines Adjuvants Revenue Share by Country (2018-2029)
Figure 48. Europe Biological Vaccines Adjuvants Sales Share by Country (2018-2029)
Figure 49. Germany Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 50. France Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 54. China Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 55. China Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 56. China Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 57. China Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 58. Asia Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 59. Asia Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 60. Asia Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 61. Asia Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 62. Asia Biological Vaccines Adjuvants Revenue Share by Region (2018-2029)
Figure 63. Asia Biological Vaccines Adjuvants Sales Share by Region (2018-2029)
Figure 64. Japan Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 68. India Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Biological Vaccines Adjuvants Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Biological Vaccines Adjuvants Sales Share by Country (2018-2029)
Figure 75. Brazil Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Biological Vaccines Adjuvants Revenue (2018-2029) & (US$ Million)
Figure 80. Biological Vaccines Adjuvants Value Chain
Figure 81. Biological Vaccines Adjuvants Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed